Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

MDT – Medtronic Plc

MDT — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

1.14

Margin Of Safety %

41

Put/Call OI Ratio

0.44

EPS Next Q Diff

0.02

EPS Last/This Y

0.04

EPS This/Next Y

0.52

Price

76.19

Target Price

107.62

Analyst Recom

1.85

Performance Q

-24.62

Upside

3.4%

Beta

0.62

Ticker: MDT




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-14MDT88.10.560.40126181
2026-04-15MDT87.110.550.32127508
2026-04-16MDT85.640.520.31133410
2026-04-17MDT86.180.480.31140540
2026-04-20MDT85.010.540.22115171
2026-04-21MDT820.520.27121033
2026-04-22MDT83.210.490.33128703
2026-04-23MDT83.780.480.21133601
2026-04-24MDT83.340.481.46135463
2026-04-27MDT82.920.530.34127408
2026-04-28MDT81.880.530.34130617
2026-04-29MDT79.360.520.85134832
2026-04-30MDT80.960.520.66140910
2026-05-01MDT800.520.48145373
2026-05-04MDT78.30.510.84140958
2026-05-05MDT77.770.520.46147980
2026-05-06MDT77.60.510.44150458
2026-05-07MDT77.960.500.74153226
2026-05-08MDT76.130.500.58154400
2026-05-11MDT74.570.500.22154567
2026-05-12MDT76.810.440.44172537
2026-05-13MDT76.190.440.41174488
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-14MDT88.10-4.8494.55.52
2026-04-15MDT87.10-4.8421.35.52
2026-04-16MDT85.65-4.8392.25.52
2026-04-17MDT86.18-4.8523.85.52
2026-04-20MDT85.00-4.8408.75.52
2026-04-21MDT81.99-3.7285.15.55
2026-04-22MDT83.21-3.7572.45.55
2026-04-23MDT83.79-3.7526.75.55
2026-04-24MDT83.34-3.7457.35.55
2026-04-27MDT82.92-3.7460.65.55
2026-04-28MDT81.89-4.2417.05.54
2026-04-30MDT80.96-4.5601.25.53
2026-05-01MDT80.00-4.5419.55.53
2026-05-04MDT78.29-4.5366.65.53
2026-05-05MDT77.76-4.5449.45.53
2026-05-06MDT77.58-4.5474.95.53
2026-05-07MDT77.94-4.5513.15.53
2026-05-08MDT76.12-4.5354.95.53
2026-05-11MDT74.53-4.5368.25.53
2026-05-12MDT76.82-4.5659.25.53
2026-05-13MDT76.19-4.5442.15.53
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-14MDT00.181.33
2026-04-15MDT00.181.33
2026-04-16MDT00.181.33
2026-04-17MDT00.181.33
2026-04-20MDT00.181.33
2026-04-21MDT00.181.33
2026-04-22MDT00.181.32
2026-04-23MDT-6.670.181.32
2026-04-24MDT-6.670.181.32
2026-04-27MDT-6.67-0.201.20
2026-04-28MDT-6.67-0.201.20
2026-04-29MDT-6.67-0.201.20
2026-04-30MDT-6.67-0.201.20
2026-05-01MDT-6.67-0.201.20
2026-05-04MDT-6.670.091.20
2026-05-05MDT-6.670.091.20
2026-05-06MDT-6.670.091.20
2026-05-07MDT-6.670.091.20
2026-05-08MDT-6.670.091.20
2026-05-11MDT-6.670.161.20
2026-05-12MDT-6.670.161.14
2026-05-13MDT-6.670.161.14
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

1.36

Avg. EPS Est. Current Quarter

1.55

Avg. EPS Est. Next Quarter

1.38

Insider Transactions

-6.67

Institutional Transactions

0.16

Beta

0.62

Average Sales Estimate Current Quarter

9622

Average Sales Estimate Next Quarter

9337

Fair Value

107.76

Quality Score

84

Growth Score

83

Sentiment Score

47

Actual DrawDown %

43.9

Max Drawdown 5-Year %

-45.1

Target Price

107.62

P/E

21.27

Forward P/E

12.58

PEG

2.15

P/S

2.76

P/B

2

P/Free Cash Flow

18.08

EPS

3.58

Average EPS Est. Cur. Y​

5.53

EPS Next Y. (Est.)

6.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13

Relative Volume

1.2

Return on Equity vs Sector %

-17.4

Return on Equity vs Industry %

-2.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

442.1
MDT Healthcare
$76.19
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
2/20
Pullback
23/25
Volume
4/15
Valuation
20/20
TP/AR
1/10
Options
5/10
RSI
32.3
Range 1M
12.2%
Sup Dist
1.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
31 /100
WEAK
Momentum
6/25
Growth
9/30
Estimates
6/20
Inst/Vol
4/15
Options
6/10
EPS Yr
0.5%
EPS NY
9.8%
52W%
5.5%
💎
Long-Term Value
Quality companies, undervalued
46 /100
WEAK
🟢 BUY +58.2% upside
Quality
10/30
Valuation
22/30
Growth
6/25
Stability
7/10
LT Trend
1/5
Upside
+58.2%
Quality
84
MoS
41%
Medtronic plc.
Sector: Healthcare
Industry: Medical Devices
Employees: 95000
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
MDT

Latest News

Caricamento notizie per MDT
stock quote shares MDT – Medtronic Plc Stock Price stock today
news today MDT – Medtronic Plc stock forecast ,stock prediction 2023 2024 2025
marketwatch MDT – Medtronic Plc yahoo finance google finance
stock history MDT – Medtronic Plc invest stock market
stock prices MDT premarket after hours
ticker MDT fair value insiders trading

MDT – Medtronic plc

MDT — Price & Float Short
—— Fair value ★ EPS beat ★ EPS miss —— Target Price
Float Short %

Float Short %

1.14

Margin Of Safety %

41

Put/Call OI Ratio

0.44

EPS Next Q Diff

0.02

EPS Last/This Y

0.04

EPS This/Next Y

0.52

Price

76.19

Target Price

107.62

Analyst Recom

1.85

Performance Q

-24.62

Upside

3.4%

Beta

0.62

Ticker: MDT




22 items of 1

DateSymbolLatestP/C OIP/C VolTotal OI
2026-04-14MDT88.10.560.40126181
2026-04-15MDT87.110.550.32127508
2026-04-16MDT85.640.520.31133410
2026-04-17MDT86.180.480.31140540
2026-04-20MDT85.010.540.22115171
2026-04-21MDT820.520.27121033
2026-04-22MDT83.210.490.33128703
2026-04-23MDT83.780.480.21133601
2026-04-24MDT83.340.481.46135463
2026-04-27MDT82.920.530.34127408
2026-04-28MDT81.880.530.34130617
2026-04-29MDT79.360.520.85134832
2026-04-30MDT80.960.520.66140910
2026-05-01MDT800.520.48145373
2026-05-04MDT78.30.510.84140958
2026-05-05MDT77.770.520.46147980
2026-05-06MDT77.60.510.44150458
2026-05-07MDT77.960.500.74153226
2026-05-08MDT76.130.500.58154400
2026-05-11MDT74.570.500.22154567
2026-05-12MDT76.810.440.44172537
2026-05-13MDT76.190.440.41174488
DateSymbolLatestP/C OIP/C VolTotal OI
22 items Current Page1 of 1




21 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2026-04-14MDT88.10-4.8494.55.52
2026-04-15MDT87.10-4.8421.35.52
2026-04-16MDT85.65-4.8392.25.52
2026-04-17MDT86.18-4.8523.85.52
2026-04-20MDT85.00-4.8408.75.52
2026-04-21MDT81.99-3.7285.15.55
2026-04-22MDT83.21-3.7572.45.55
2026-04-23MDT83.79-3.7526.75.55
2026-04-24MDT83.34-3.7457.35.55
2026-04-27MDT82.92-3.7460.65.55
2026-04-28MDT81.89-4.2417.05.54
2026-04-30MDT80.96-4.5601.25.53
2026-05-01MDT80.00-4.5419.55.53
2026-05-04MDT78.29-4.5366.65.53
2026-05-05MDT77.76-4.5449.45.53
2026-05-06MDT77.58-4.5474.95.53
2026-05-07MDT77.94-4.5513.15.53
2026-05-08MDT76.12-4.5354.95.53
2026-05-11MDT74.53-4.5368.25.53
2026-05-12MDT76.82-4.5659.25.53
2026-05-13MDT76.19-4.5442.15.53
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
21 items Current Page1 of 1




22 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2026-04-14MDT00.181.33
2026-04-15MDT00.181.33
2026-04-16MDT00.181.33
2026-04-17MDT00.181.33
2026-04-20MDT00.181.33
2026-04-21MDT00.181.33
2026-04-22MDT00.181.32
2026-04-23MDT-6.670.181.32
2026-04-24MDT-6.670.181.32
2026-04-27MDT-6.67-0.201.20
2026-04-28MDT-6.67-0.201.20
2026-04-29MDT-6.67-0.201.20
2026-04-30MDT-6.67-0.201.20
2026-05-01MDT-6.67-0.201.20
2026-05-04MDT-6.670.091.20
2026-05-05MDT-6.670.091.20
2026-05-06MDT-6.670.091.20
2026-05-07MDT-6.670.091.20
2026-05-08MDT-6.670.091.20
2026-05-11MDT-6.670.161.20
2026-05-12MDT-6.670.161.14
2026-05-13MDT-6.670.161.14
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
22 items Current Page1 of 1

Last Quarter Act. EPS

1.36

Avg. EPS Est. Current Quarter

1.55

Avg. EPS Est. Next Quarter

1.38

Insider Transactions

-6.67

Institutional Transactions

0.16

Beta

0.62

Average Sales Estimate Current Quarter

9622

Average Sales Estimate Next Quarter

9337

Fair Value

107.76

Quality Score

84

Growth Score

83

Sentiment Score

47

Actual DrawDown %

43.9

Max Drawdown 5-Year %

-45.1

Target Price

107.62

P/E

21.27

Forward P/E

12.58

PEG

2.15

P/S

2.76

P/B

2

P/Free Cash Flow

18.08

EPS

3.58

Average EPS Est. Cur. Y​

5.53

EPS Next Y. (Est.)

6.06

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

13

Relative Volume

1.2

Return on Equity vs Sector %

-17.4

Return on Equity vs Industry %

-2.4

EPS 1 7Days Diff

EPS 1 30Days Diff

-0.01

EBIT Estimation

442.1
MDT Healthcare
$76.19
📉
Swing / Pullback
Buy the dip on strong trends
N/A
0 /100
WEAK
Trend
2/20
Pullback
23/25
Volume
4/15
Valuation
20/20
TP/AR
1/10
Options
5/10
RSI
32.3
Range 1M
12.2%
Sup Dist
1.2%
🚀
Momentum Growth
Ride accelerating trends
N/A
31 /100
WEAK
Momentum
6/25
Growth
9/30
Estimates
6/20
Inst/Vol
4/15
Options
6/10
EPS Yr
0.5%
EPS NY
9.8%
52W%
5.5%
💎
Long-Term Value
Quality companies, undervalued
46 /100
WEAK
🟢 BUY +58.2% upside
Quality
10/30
Valuation
22/30
Growth
6/25
Stability
7/10
LT Trend
1/5
Upside
+58.2%
Quality
84
MoS
41%
Medtronic plc.
Sector: Healthcare
Industry: Medical Devices
Employees: 95000
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, and percutaneous coronary intervention products, percutaneous angioplasty balloons, and other products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. The segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products. The Diabetes Operating Unit segment provides insulin pumps and consumables, continuous glucose monitoring systems and sensors, and InPen, a smart insulin pen. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.
MDT

Latest News

Caricamento notizie per MDT
stock quote shares MDT – Medtronic plc Stock Price stock today
news today MDT – Medtronic plc stock forecast ,stock prediction 2023 2024 2025
marketwatch MDT – Medtronic plc yahoo finance google finance
stock history MDT – Medtronic plc invest stock market
stock prices MDT premarket after hours
ticker MDT fair value insiders trading